AI and VR Devices for Eating Behavior Rehabilitation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15-40
SponsorIstituto per la Ricerca e l'Innovazione Biomedica
About this trial
Eating disorders (ED) affect the relationship with food and body image. Virtual reality (VR), combined with artificial intelligence (AI), offers new clinical solutions, overcoming traditional cognitive behavioral therapy (CBT). The ARCADIA VR project aims to develop devices to treat ED through personalized VR systems (e.g. Enhanced Body-Swap for anorexia, Emotional Rescripting for bulimia) and AI predictive algorithms to monitor severity, risk and efficacy of treatments. These approaches promise better and faster results, improving diagnosis and treatment.
Eligibility criteria
Qualifiers
Clinical diagnosis of Anorexia Nervosa or Bulimia Nervosa according to DSM-5-TR (APA, 2013) and ICD-11, confirmed by a public hospital setting
Body Mass Index (BMI) between 16 and 32
Disorder present for at least 6 months
No other concurrent psychotherapeutic interventions during the study
Disqualifiers
None
Trial design
Treatments tested in this trial
- Enhanced Body-Swap for Anorexia Nervosa
- Emotional Rescripting for Bulimia Nervosa
- Standard Therapy for Anorexia Nervosa (Control)
- Standard Therapy for Bulimia Nervosa (Control)
Treatment groups
80 Participants
are divided into 4 treatment groupsSponsors and collaborators
Istituto per la Ricerca e l'Innovazione Biomedica
Lead sponsor
Madre Teresa s.r.l
Collaborator
Medilink s.r.l.
Collaborator
SB SETEC S.p.A
Collaborator
Catholic University of the Sacred Heart
Collaborator
Source ClinicalTrials.gov